GSA Capital Partners’s Claritev CTEV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$773K Buy
36,518
+23,859
+188% +$752K 0.05% 760
2026
Q2
$432K Sell
12,659
-1,632
-11% -$40K 0.03% 1091
2026
Q1
$234K Buy
14,291
+2,168
+18% +$48.6K 0.01% 1378
2025
Q4
$518K Buy
+12,123
New +$617K 0.04% 782
2023
Q2
– Sell
-13,017
Closed -$552K – 2018
2023
Q1
$552K Buy
13,017
+10,606
+440% +$479K 0.05% 651
2022
Q4
$111K Buy
2,411
+500
+26% +$39.9K 0.01% 1294
2022
Q3
$219K Buy
+1,911
New +$316K 0.03% 1162
2021
Q4
– Sell
-1,890
Closed -$426K – 1862
2021
Q3
$426K Buy
+1,890
New +$511K 0.04% 791
2021
Q1
– Sell
-458
Closed -$146K – 1558
2020
Q4
$146K Buy
+458
New +$152K 0.02% 1055

Other funds holding CTEV

GSA Capital Partners's CTEV Position: Q3 2026 in Review

GSA Capital Partners increased its Claritev (CTEV) stake by 188% in Q3 2026, buying an estimated $752K and bringing the position to 36,518 shares worth $773K. The position accounts for 0.05% of the portfolio, ranked #760.

GSA Capital Partners first reported a position in CTEV in Q4 2020 and has held it in 9 quarters since. 106 funds tracked by Wall St. Rank hold CTEV as of Q3 2026.

  • GSA Capital Partners held 36,518 shares of Claritev worth $773K as of Q3 2026.
  • GSA Capital Partners bought 23,859 Claritev shares in Q3 2026, an estimated $752K.
  • Claritev made up 0.05% of GSA Capital Partners's portfolio in Q3 2026, its #760 holding.
  • GSA Capital Partners first reported a position in Claritev in Q4 2020 and has held it in 9 quarters since.
  • 106 funds tracked by Wall St. Rank held Claritev as of Q3 2026.

Based on GSA Capital Partners's 13F filing for Q3 2026, filed 16 Nov 2026.